Sadako Yoshizawa

Sadako Yoshizawa

Auto-generated profile, based on publicly available information

Sadako Yoshizawa

Toho University School of Medicine

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2024 in American Journal of Infection Control
Verified
Journal Article
Open access
MTMayumi Tsukada
Mayumi Tsukada
TMTaito Miyazaki
Taito Miyazaki
KAKotaro Aoki
Kotaro Aoki
SYSadako Yoshizawa
Sadako Yoshizawa
YKYoko Kondo
Yoko Kondo
KTKazuhiro Tateda
Kazuhiro Tateda
This study describes an outbreak caused by multispecies carbapenemase-producing Enterobacterales (CPE) occurring in a pediatric ward at an academic medical center in Tokyo. The index case involved a 1-year-old boy with Klebsiella variicola (CPE) detected in anal swabs in June 2016. The second case was Klebsiella quasipneumoniae (CPE) occurred in March 2017 followed by further spread, leading to the declaration of an outbreak in April 2017. Extensive environmental and patient microbiological sampling was performed. The relatedness of the isolates was determined using draft-whole-genome sequencing. CPE surveillance cultures of patients and environments were positive in 19 patients and 9 sinks in the ward. The sinks in hospital rooms uninhabited by CPE patients exhibited no positive CPE-positive specimen during the outbreak. All CPE strains analyzed using draft-whole-genome sequencing harbored blaIMP-1, except for one harboring blaIMP-11; these strains harbored identical blaIMP-1-carrying IncM1 plasmids. CPE was detected even after sink replacement; infection-control measures focused on sinks were implemented and the CPE outbreak ended after 7 months. Multiple bacterial species can become CPE via blaIMP-1-carrying IncM1 plasmids of the same origin and spread through sinks in a hospital ward. Thorough infection-control measures implemented as a bundle might be crucial.

1 April 2012 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
SYSadako Yoshizawa
Sadako Yoshizawa
KTKazuhiro Tateda
Kazuhiro Tateda
TSTomoo Saga
Tomoo Saga
YIYoshikazu Ishii
Yoshikazu Ishii
KYKeizo Yamaguchi
Keizo Yamaguchi
In the present study, immunomodulatory effects of linezolid (LZD) on methicillin-resistance Staphylococcus aureus (MRSA) infections were evaluated. We have retrospectively reviewed treatment effects of LZD on 52 patients with severe MRSA infections. Sixty-four percent of the febrile patients demonstrated significant defervescence within 3 days, despite the presence of positive culture results. We speculated that this finding might be due to early anti-inflammatory effects of LZD, and to investigate this further we initiated in vivo experiments using mice MRSA pneumonia models. Mice were treated with either LZD or vancomycin (VCM) immediately after intranasal administration of MRSA. Bacterial numbers and levels of inflammatory cytokines in the lungs were determined. Although the bacterial burden in the lungs was not apparently different between the two groups, LZD but not VCM treatment significantly reduced induction of inflammatory cytokines in the lungs ( P < 0.05). To evaluate whether this anti-inflammatory response was due to suppression of virulence factor expression, filter-sterilized supernatants of MRSA incubated in broth overnight with sub-MICs of LZD were subcutaneously administered to mice. To clarify whether LZD possesses direct host-modulating activity, cytokine responses to the supernatants were examined in mice pretreated with LZD. Interestingly, MRSA solutions prepared in the presence of sub-MICs of LZD revealed significant suppression of interleukin 6 (IL-6) in a dose-dependent manner ( P < 0.05), but pretreatment of mice with LZD revealed no changes in cytokines. These findings suggest that sub-MICs of LZD might suppress virulence factors of MRSA, which may be associated with a reduction in endogenous pyrogens. These data may explain at least in part early defervescence observed in LZD-treated individuals.

11 August 2010 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
YOYoichiro Okubo
Yoichiro Okubo
MSMinoru Shinozaki
Minoru Shinozaki
SYSadako Yoshizawa
Sadako Yoshizawa
Haruo NakayamaHaruo Nakayama
Haruo Nakayama
MWMegumi Wakayama
Megumi Wakayama
KSKazutoshi Shibuya
Kazutoshi Shibuya
Introduction: Toxoplasmosis can be a life-threatening disease when it occurs in patients with HIV infection. In particular, meningioencephalitis has been regarded as the most common toxoplasmic complication in such patients. However, toxoplasmic meningitis in a patient with HIV infection is extremely rare and purulent or tuberculous meningitis should be considered initially as a disease for differential diagnosis in Japan. Case presentation: Toxoplasmic meningitis in a patient with HIV infection is reported. A 36-year-old Japanese man presented with fever, pulsating headache, lumbago, nausea, and vomiting. No examinations suggested toxoplasmosis including cerebrospinal fluid examinations, images, and serological tests. The result of a polymerase chain reaction assay using paraffin-embedded section was regarded as the conclusive evidence for the diagnosis. Conclusions: We wish to emphasize the usefulness of polymerase chain reaction assays with nucleic acid extracted from paraffin-embedded tissue sections processed for routine histopathological examination, if the section shows the infectious agents or findings suggesting some infectious diseases.

22 January 2022 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
YHYuki Hanai
Yuki Hanai
SYSadako Yoshizawa
Sadako Yoshizawa
KMKazuhiro Matsuo
Kazuhiro Matsuo
SUShusuke Uekusa
Shusuke Uekusa
TMTaito Miyazaki
Taito Miyazaki
KNKenji Nishizawa
Kenji Nishizawa

18 December 2023 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
TMTakeo Mori
Takeo Mori
SYSadako Yoshizawa
Sadako Yoshizawa
KYKageto Yamada
Kageto Yamada
TSTakahiro Sato
Takahiro Sato
MSMasakazu Sasaki
Masakazu Sasaki
KTKazuhiro Tateda
Kazuhiro Tateda
Background: Pseudomonas otitidis belongs to the genus Pseudomonas and causes various infections, including ear, skin, and soft tissue infections. P. otitidis has a unique susceptibility profile, being susceptible to penicillins and cephalosporins but resistant to carbapenems, due to the production of the metallo-β-lactamase called POM-1. This revealed genetic similarities with Pseudomonas aeruginosa, which can sometimes lead to misidentification. Case presentation: We report the case of a 70-year-old Japanese male who developed cellulitis and bacteremia during chemotherapy for multiple myeloma. He was initially treated with meropenem, but blood culture later revealed gram-negative bacilli identified as P. otitidis using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). Carbapenem resistance was predicted from previous reports; therefore, we switched to dual therapy with levofloxacin and cefepime, and favorable treatment results were obtained. Conclusion: This is the first reported case of P. otitidis cellulitis and bacteremia in an immunocompromised patient. Carbapenems are typically used in immunocompromised patients and P. otitidis is often resistant to it. However, its biochemical properties are similar to those of Pseudomonas aeruginosa; therefore, its accurate identification is critical. In the present study, we rapidly identified P. otitidis using MALDI-TOF MS and switched from carbapenems to an appropriate antimicrobial therapy, resulting in a successful outcome.

5 May 2024 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
HKHiroyuki Kunishima
Hiroyuki Kunishima
KIKaoru Ichiki
Kaoru Ichiki
HOHiroki Ohge
Hiroki Ohge
FSFumie Sakamoto
Fumie Sakamoto
YSYuka Sato
Yuka Sato
SYSadako Yoshizawa
Sadako Yoshizawa